Conditions,Treatment,Results,Evidence
Human schwannoma,treat with Ponatinib,decreases viability of merlin-deficient HSC and vestibular schwannoma (VS) cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458238/
